Old Web
English
Sign In
Acemap
>
authorDetail
>
Kay Greveson
Kay Greveson
Royal Free Hospital
Medicine
Diabetes mellitus
Inflammatory bowel disease
Internal medicine
Biosimilar
6
Papers
195
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Barriers to international travel in inflammatory bowel disease patients.
2020
Journal of Travel Medicine
Kristina Aluzaite
Kay Greveson
Shomron Ben-Horin
Rupert W. Leong
Ola Haj
Michael Schultz
Show All
Source
Cite
Save
Citations (6)
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
2020
Drugs
HoUng Kim
Rieke Alten
Luisa Avedano
Axel Dignass
Fernando Gomollón
Kay Greveson
Jonas Halfvarson
Peter M. Irving
Jørgen Jahnsen
Peter L. Lakatos
JongHyuk Lee
Souzi Makri
Ben Parker
Laurent Peyrin-Biroulet
Stefan Schreiber
Steven Simoens
Rene Westhovens
Silvio Danese
Ji Hoon Jeong
Show All
Source
Cite
Save
Citations (25)
Anti-TNF biosimilars in Crohn’s Disease: a patient-centric interdisciplinary approach
2019
Expert Review of Gastroenterology & Hepatology
Laurent Peyrin-Biroulet
Silvio Danese
Fraser Cummings
Raja Atreya
Kay Greveson
Burkhard Pieper
Taegyun Kang
Show All
Source
Cite
Save
Citations (7)
A Global Survey of Gastroenterologists’ Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas
2018
Journal of Crohns & Colitis
Webber Chan
Hang Hock Shim
Siew C. Ng
Jeffrey Liu
Christian Inglis
Kay Greveson
Brandon Baraty
Craig Haifer
Rupert W. Leong
Show All
Source
Cite
Save
Citations (6)
1